He R - Search Results

1

Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.

Wang H, Fu C, Du J, Wang H, He R, Yin X, Li H, Li X, Wang H, Li K, Zheng L, Liu Z, Qiu Y. Wang H, et al. Among authors: he r. J Exp Clin Cancer Res. 2020 Feb 5;39(1):29. doi: 10.1186/s13046-020-1536-x. J Exp Clin Cancer Res. 2020. PMID: 32024543 Free PMC article.

2

Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.

Huang Y, Chen G, Wang Y, He R, Du J, Jiao X, Tai Q. Huang Y, et al. Among authors: he r. Biochem Biophys Res Commun. 2018 Sep 5;503(2):1035-1041. doi: 10.1016/j.bbrc.2018.06.113. Epub 2018 Aug 2. Biochem Biophys Res Commun. 2018. PMID: 29935185

3

Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China.

Jiao X, Wu Y, Zhou L, He J, Yang C, Zhang P, Hu R, Luo C, Du J, Fu J, Shi J, He R, Li D, Jun W. Jiao X, et al. Among authors: he j, he r. Sci Rep. 2015 Dec 15;5:18160. doi: 10.1038/srep18160. Sci Rep. 2015. PMID: 26668074 Free PMC article.

4

Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.

Zhang P, Cao P, Zhu X, Pan M, Zhong K, He R, Li Y, Jiao X, Gao Y. Zhang P, et al. Among authors: he r. Oncotarget. 2017 May 16;8(20):33137-33143. doi: 10.18632/oncotarget.16561. Oncotarget. 2017. PMID: 28388535 Free PMC article.

5

FOXF2 deficiency permits basal-like breast cancer cells to form lymphangiogenic mimicry by enhancing the response of VEGF-C/VEGFR3 signaling pathway.

Wang QS, He R, Yang F, Kang LJ, Li XQ, Fu L, Sun B, Feng YM. Wang QS, et al. Among authors: he r. Cancer Lett. 2018 Apr 28;420:116-126. doi: 10.1016/j.canlet.2018.01.069. Epub 2018 Jan 31. Cancer Lett. 2018. PMID: 29409810

6

Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.

Yu ZH, Lun SM, He R, Tian HP, Huang HJ, Wang QS, Li XQ, Feng YM. Yu ZH, et al. Among authors: he r. Cancer Lett. 2017 Aug 28;402:142-152. doi: 10.1016/j.canlet.2017.05.020. Epub 2017 May 31. Cancer Lett. 2017. PMID: 28577976

7

DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.

Tian HP, Lun SM, Huang HJ, He R, Kong PZ, Wang QS, Li XQ, Feng YM. Tian HP, et al. Among authors: he r. J Biol Chem. 2015 Jul 31;290(31):19173-83. doi: 10.1074/jbc.M114.636126. Epub 2015 Jun 12. J Biol Chem. 2015. PMID: 26070560 Free PMC article.

8

FOXF2 reprograms breast cancer cells into bone metastasis seeds.

Wang S, Li GX, Tan CC, He R, Kang LJ, Lu JT, Li XQ, Wang QS, Liu PF, Zhai QL, Feng YM. Wang S, et al. Among authors: he r. Nat Commun. 2019 Jun 20;10(1):2707. doi: 10.1038/s41467-019-10379-7. Nat Commun. 2019. PMID: 31222004 Free PMC article.

9

FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.

Zhang X, Zhang R, Hou C, He R, Wang QS, Zhou TH, Li XQ, Zhai QL, Feng YM. Zhang X, et al. Among authors: he r. J Biol Chem. 2022 Jul;298(7):102082. doi: 10.1016/j.jbc.2022.102082. Epub 2022 May 31. J Biol Chem. 2022. PMID: 35660418 Free PMC article.

10

Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.

Tan CC, Li GX, Tan LD, Du X, Li XQ, He R, Wang QS, Feng YM. Tan CC, et al. Among authors: he r. Oncotarget. 2016 Nov 29;7(48):79688-79705. doi: 10.18632/oncotarget.12939. Oncotarget. 2016. PMID: 27806311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,137 results

Search Page

Filters